Skip to main navigation Skip to search Skip to main content

Evaluating the breast cancer quality of care indicators in Iran; multicenter study

  • Mojtaba Vand Rajabpour
  • , Monireh Sadat Seyyedsalehi
  • , Azin Nahvijou
  • , Saeed Nemati
  • , Shaghayegh Haghjooy Javanmard
  • , Amirreza Manteghinejad
  • , Sepideh Abdi
  • , Borna Farazmand
  • , Habibollah Pirnejad
  • , Arash Golpazir Sorkheh
  • , Jamshid Anasari
  • , Masoud Bahrami
  • , Maryam Marzban
  • , Seyedeh Masoumeh Ghoreishi
  • , Yahya Baharvand Iran Nia
  • , Fataneh Bakhshi
  • , Alireza Ansari-Moghaddam
  • , Maryam Moradi Binabaj
  • , Hassan Nourmohammadi
  • , Ramesh Omranipour
  • Alireza Abdollahi, Mahdi Aghili, Mohammad Ali Mohagheghi, Ali Ghanbari-Motlagh, Partha Basu, Paolo Boffetta, Kazem Zendehdel
  • Tehran University of Medical Sciences
  • Isfahan University of Medical Sciences
  • Urmia University of Medical Sciences
  • Kermanshah University of Medical Sciences
  • Arak University of Medical Sciences
  • Bushehr University of Medical Sciences
  • Babol University of Medical Sciences
  • Lorestan University of Medical Sciences
  • Guilan University of Medical Sciences
  • Zahedan University of Medical Sciences
  • Sabzevar University of Medical Sciences
  • Mostafa Khomeini Hospital
  • Shahid Beheshti University of Medical Sciences
  • International Agency for Research on Cancer

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Data on quality-of-care indicators for breast cancer patients is limited in low—and middle-income countries. We evaluated the indicators in Iran. Method: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran. Result: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels. Conclusion: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low—and middle-income countries.

Original languageEnglish
Article number925
JournalBMC Cancer
Volume25
Issue number1
DOIs
StatePublished - Dec 2025

Keywords

  • Breast Neoplasm
  • Countries
  • Developing
  • EUSOMA
  • Healthcare
  • Indicators
  • Quality of Care
  • System

Fingerprint

Dive into the research topics of 'Evaluating the breast cancer quality of care indicators in Iran; multicenter study'. Together they form a unique fingerprint.

Cite this